Is pemetinib/pemetinib tablets included in medical insurance?

Pemigatinib The original drug has been marketed in China and has not yet passed the relevant regulations of the National Medical Insurance Bureau to enter the ranks of medical insurance. As for when pemetinib can be included in medical insurance, it depends on many factors, including the clinical effect of the drug, cost-benefit analysis, and national and regional medical insurance policies. Usually, new drugs need to go through a period of clinical use and evaluation before they can be considered for inclusion in the medical insurance catalog.

Pemetinib is a prescription drug used to treat cholangiocarcinoma and myeloid lymphoid neoplasm (MLN) that have certain genetic markers. For adults with cholangiocarcinoma, if the cancer has a genetic mutation in the fibroblast growth factor receptor (FGFR) protein, style="font-family:宋体;font-size:10.5pt;">has spread to other parts of the body or has spread to nearby tissue but cannot be removed by surgery, or Having received other cancer drug treatmentscan be treated with pemetinib. For adults with myeloid lymphoma, if the cancer has gene mutations in the FGFR protein, orPrevious cancer drug treatment was unsuccessful or recurrence after previous treatment, may also be treated with pemetinib.

Pemetinib is a pill that can be swallowed. PemigatinibContains the active ingredient pemigatinib. (The active ingredient is the basis for the drug to work.) PemetinibAvailable as oral tablets in three strengths:4.5 mg, 9 mg and 13.5 mg. The dosage will depend on the type of cancer, and your doctor will recommend a dosage that is appropriate for the patient. The most common side effects of pemetinib are hair loss, diarrhea, nail problems, fatigue, nausea, dysgeusia, stomatitis, constipation, joint pain, dry mouth, dry eyes and skin, rash and numbness on the palms and soles.